本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

26.21
+1.455.86%
盘前26.210.00000.00%08:12 EDT
成交量:60.93万
成交额:1,603.03万
市值:15.51亿
市盈率:-19.20
高:26.88
开:25.01
低:25.01
收:24.76
数据加载中...
2024/11/05

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities